Myoglobin (Mb) is a protein that enters rapidly and is rapidly cleared from plasma after coronary reperfusion. We sought to determine the accuracy with which a rapid rise in plasma [Mb] could predict successful coronary artery reopening in patients undergoing coronary arteriography in conjunction with attempted reperfusion in acute myocardial infarction. In 42 patients, plasma Mb levels were measured before and for at least 4 hours after attempted reperfusion. Thirty-five patients were successfully reperfused. In each, the plasma Mb level rose rapidly with peak [Mb] occurring at 111±8.1 (±SEM) minutes after application of therapy. In contrast, Mb levels rose more slowly in the seven patients who were not reperfused, with peak
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[Mb] occurring 360±61.4 minutes after attempted reperfusion. T25-100 (the time required for
[Mb] to rise from 25% to 100% of peak value) was shorter in patients successfully reperfused (71±7.9 minutes) and longer (341±35.3 minutes) in patients in whom therapy was unsuccessful. A rapid rise in [Mb] after successful reperfusion was also evident by a more than 4.6-fold rise in [Mb] over the first 2 hours after reperfusion in all but five patients; in contrast, [Mb] rose by less than 4.6-fold over this same interval in every patient not successfully reperfused (sensitivity, 85%; specificity, 100%; predictive accuracy, 88%). We September 1, 1984 , and December 31, 1987. All patients had prolonged chest pain when they presented to the emergency department. Entry into the study also required that the pain be less than 6 hours in duration, be unrelieved by sublingual nitroglycerin and/or nifedipine, and be associated with 0.1 mV ST elevation in at least two adjacent electrocardiographic leads. In addition, cardiogenic shock, renal failure, intramuscular injections, and arrhythmias requiring cardioversion were required to not present. Ten of the patients were included in an earlier study. 1 After each patient had given informed consent, a 3 -ml venous sample for blood Mb level determination was drawn before the acute intervention. After application of therapy, 3-ml samples were to be drawn every 30 minutes for 4 hours and then every 4 hours for an additional 20 hours; however, because of patient care factors, it was not possible to obtain every sample in each patient. Treatments varied depending on the clinical circumstance but included intravenous streptokinase (IV SK), intracoronary streptokinase (IC SK), PTCA, and intravenous recombinant tissue-type plasminogen activator (IV rt-PA). IV SK was given as 1,500,000 units over 30-45 minutes; rt-PA was administered in either a standard dose (1.25 mg/kg/3 hr) or high dose (2.00 mg/kg/3 hr); IC SK was given as a 62,500-unit bolus into the infarct-related artery followed by an infusion of 4,000-6,000 units/min/ 40-60 min. Patients receiving IV rt-PA or IC SK underwent immediate cardiac catheterization, and the status of the infarct-related artery was determined; in these patients, PTCA was attempted if it was thought to be clinically indicated (e.g., unsuccessful thrombolysis and/or high-grade residual stenosis). All patients were subsequently anticoagulated with intravenous heparin to maintain the activated partial thromboplastin time at from one and one half to two control; otherwise, patients received routine coronary care, including nitrates, calcium channel blockers, fl-blockers, and antiarrhythmic agents as needed.
The patency of the infarct-related artery was assessed by coronary arteriography in all patients. As just noted, patients receiving IC SK, intravenous rt-PA, and/or PTCA underwent arteriography at the time of application of therapy. Patients receiving IV SK underwent coronary arteriography within 2±0.3 (8SEM) days (range, 1-5 days) after attempted thrombolysis; in all but two patients, arteriography was actually performed within 3 days. The arteriograms were reviewed by at least two experienced angiographers who were unaware of the results of the Mb determinations.
Plasma Mb levels were determined in each sample by radioimmunoassay (NMS Radiopharmaceuticals, Newport Beach, California), and an Mb concentration-time curve plotted for each patient. The coefficient of variation for myoglobin determination by this assay was -4%. Time 0 was taken as the time of application of therapy; in patients in whom thrombolysis was followed by PTCA, the time of the intervention that resulted in vessel reopening was designated time 0. All values groups) with a time-to-peak of 77±11.9 minutes. In nine of these 21 patients, the infarct-related artery was occluded at the time of initial arteriography; in each case, plasma Mb levels drawn just before arteriography were low and began to rise rapidly after successful reopening of the occluded vessel ( Figure 3 rise from 25% to 100% of peak value). As summarized in Table 2 and Figure 4, ( Figure 5 ). An increase in [Mb] of at least 4.6-fold over the first 2 hours was present in 29 of 34 patients successfully reperfused, whereas this ratio was less than 4.6 in all six patients in whom therapy was unsuccessful. Similar Figure 3 , the rapid rise in [Mb] In each of the 14 patients receiving IV SK in whom the infarct-related artery was noted to be patent at the time of coronary arteriography, there was an early, discrete peak in the Mb concentrationtime curve. Because immediate angiography was not performed, this group may include patients in whom the infarct-related artery was never totally occluded and/or patients in whom spontaneous vessel reopening occurred within the first few hours of onset of symptoms. Delayed recanalization within 2-3 days, as evidenced by the lack of an early Mb peak with a patent vessel at arteriography, was not noted in any of our patients.
Several criteria have been suggested to allow noninvasive determination of vessel patency after attempted thrombolysis: relief of chest discomfort, occurrence of reperfusion arrhythmias, normalization of ST-segment elevation,8 and an early rapid rise9'10 and early peak in creatine kinase activity. 11, 12 Although the first three parameters occur commonly after successful thrombolytic therapy, each parameter is relatively insensitive when considered separately. 13"14 Although the predictive value is 100% if all three findings are present, this occurs in less than 15% of reperfused patients.'5 With regard to creatine kinase curves, successful reperfusion is associated with peak creatine kinase activity at 13±6 hours compared with 22±4 hours in patients in whom thrombolysis is unsuccessful.'6 However, the large coefficients of variation (20-50%) indicate considerable variability and overlap among individual patients in these two groups. In addition to the large scatter and overlap of peak times, the need to collect frequent samples to determine the time of peak activity further limits this approach. More recently, it has been noted that individual creatine kinase isoenzymes are composed of three isoforms based on differences in isoelectric point.'178 From initial reports it appears that the use of creatine kinase isoform analysis may be quite useful in separating successful from unsuccessful reperfusion in the first few hours after application of lytic therapy. 19, 20 The need to develop a noninvasive marker of reperfusion is important in view of the large number of patients in whom intravenous thrombolysis is now likely to be used and in whom subsequent triage becomes an important issue. Our findings indicate that the determination of blood Mb levels early in the course of attempted coronary reperfusion is a relatively simple test that appears both sensitive and specific in providing information about the patency of the infarct-related artery.
